The feature enables clinicians to see patients' nightly data, verify adherence, and spot issues, enabling them to engage patients to reach better outcomes.
Verklizan's UMO platform is currently being used to monitor more than 1,100,000 people on a daily basis.
Through the initiative, clinicians are working to proactively engage patients and improve outcomes of individuals with high-risk chronic conditions.
The partnership will launch with a pilot program with 50 individuals currently engaged with MAP and who have a history of anxiety issues.
Under the deal, Reliq's hardware and software solutions will be provided to Paz Home Health's home care clients.
The partnership will launch with a pilot program beginning in April and patients will be issued a Soberlink breathalyzer that links to their MAP profile.
This integration allows patients to share their home recorded health data such as blood pressure, weight and heart rate with their health provider seamlessly.
The two companies will work together to design what they say is the world's first wireless connected thermometer embedded into a remote patient monitoring kit.
The two companies aim to develop technology that will make it possible for non-invasive body monitoring devices to provide accurate physiological data.
The greater consumer affinity with connected devices will be accompanied by an upsurge in the adoption of platforms such as Apple Health and Google Fit.